Tag: Drug development challenges
Biotech Update: Roche’s TIGIT Struggles and Missed Alzheimer’s Target
Happy Tuesday! I'm Adam Feuerstein, and I'm here to bring you the latest updates in the world of biotech. It seems like all the big news in biotech decided to drop right before Thanksgiving,...
Exploring R&D Strategies of Amgen, Biogen, and Takeda for Challenging Targets
Amgen, Biogen, and Takeda are three biopharma companies facing challenges in developing treatments for obesity and Alzheimer's disease. At the STAT 2024 Summit in Boston, leaders from these companies discussed their research and development...
BREAKING NEWS
CDC Continues Publishing Papers Despite Firing Scientists: Flagship Journal Controversy
North Carolina Kids Find Lead in Applesauce: A Closer LookIn Hickory, North Carolina, the lead-poisoning-from-applesauce case started with two little kids showing concerning blood...
